Josol, Julito L.
HRN: 23-02-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
CO-AMOXICLAV 625MG (TAB)
05/19/2023
05/24/2023
PO
1 Tab
TID
CAP-MR
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes